Phase I/II Cabazitaxel for Recurrent Malignant Glioma
Clinical trial NCT01740570 · WITHDRAWN
Trial details
- NCT number
- NCT01740570
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2017-04-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.